Trials of a new coronavirus vaccine which could help in turning the tide across the world have been successful.
Following the development of Britain`s first vaccine, Prime Minister Boris Johnson said he hopes those who are susceptible to the virus could be immunised by Easter. At a Downing Street press conference, he said: “I don’t want to give any more hostages to fortune than that, but that’s the best information we have.”
The Oxford University/AstraZeneca vaccine could protect up to 90% of people and bring the world closer to ending the coronavirus pandemic.
Prof Sarah Gilbert from the University of Oxford, who has led the research said: “The announcement today takes us another step closer to the time when we can use vaccines to bring an end to the devastation caused by [Covid-19].
“We will continue to work to provide the detailed information to regulators. It has been a privilege to be part of this multinational effort, which will reap benefits for the whole world.”
The vaccine can also be rolled out in developing countries since it’s low-cost, at £3 a dose compared with more than £20 for the Pfizer/BioNTech and Moderna vaccines.
Scientists said the vaccine was more effective in people given a lower first dose, but they couldn`t fully explain why. The United States, where the half-dose regime was not being tested will have to conduct new trials of the vaccine.
If the US continues to delay in conducting new trials of the vaccine it could roll back efforts to find a vaccine before Christmas.